• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Caplin Point Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4464.0
  • ISIN : INE475E01026
1,999.80 -10 (-0.51%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    1,984.65

  • Today’s High

    2,040.05

  • Open

    2,039.00

  • Perv Close

    2,010.10

  • 52W Low

    1,225.00

  • 52W High

    2,641.00

Key Indicators

  • P/E(TTM)

    47.14

  • Mar.Cap (₹Cr.)

    15,200.82

  • Div & Yield %

    0.25

  • Book Value(₹)

    201.93

  • Debt-Equity Ratio

    -0.51

  • AGM Date

    28-Mar-2025

  • EPS

    42.48

  • P/E Ratio

    47.14

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    15,200.82

  • RONW (%)

    24.52

  • ROCE (%)

    26.67

Score Board

  • Equity (₹ in Cr.)

    15.20

  • BV (₹)

    201.90

  • Sales( ₹ in Cr.)

    625.09

  • NP (in Cr.)

    282.52

  • NP Var(%)

    21.0

  • Div%

    250.0

  • CPS (₹)

    40.70

  • EPS (₹)

    37.20

  • Traded Value (₹ in Lakhs)

    15,222.10

  • 52 Week High

    2,641.00

  • 52 Week Low

    1,225.00

  • Price BSE

    2003.0

  • Price NSE

    2,000.00

  • Market Capital( in Cr.)

    15,222.10

  • P/C Ratio

    49.20

  • P/E Ratio

    53.90

  • Price Vs.BV

    37.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 625.09 528.61 528.06 482.68 527.83 536.91
Excise Duty 613.41 519.28 516.82 468.16 510.45 509.16
Net Sales 625.09 528.61 528.06 482.68 527.83 536.91
Other Income 105.84 99.00 56.55 18.62 65.97 35.40
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 730.93 627.61 584.61 501.30 593.80 572.31
EXPENDITURE :
Raw Materials 613.41 519.28 516.82 468.16 510.45 509.16
Power & Fuel Cost 613.41 519.28 516.82 468.16 510.45 509.16
Employee Cost 38.11 36.68 30.47 26.59 25.00 42.01
Other Manufacturing Expenses 13.96 10.03 9.46 5.10 3.29 2.62
Selling & Administrative Expenses 39.86 40.30 43.51 28.12 38.19 40.15
Miscellaneous Expenses 13.96 10.03 9.46 5.10 3.29 2.62
Less : Pre-operative Expenses Capitalised :
Total Expenditure 365.19 334.46 334.30 291.36 340.67 369.65
Operating Profit 40.86 23.62 20.35 14.11 16.18 26.94
Interest 0.10 0.12 0.09 0.17 0.19 0.06
Gross Profit 365.74 293.15 250.31 209.94 253.12 202.65
Depreciation 27.08 25.65 25.77 22.44 19.65 20.84
Profit Before Tax 365.74 293.15 250.31 209.94 253.12 202.65
Tax 86.12 66.58 61.62 54.88 55.89 54.11
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -4.09 -7.69 0.82 -1.17 -0.40 0.38
Reported Net Profit 283.71 234.26 187.87 156.23 197.64 148.17
Extraordinary Items 365.74 293.15 250.31 209.94 253.12 202.65
Adjusted Net Profit 283.71 234.26 187.87 156.23 197.64 148.17
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 37.98 34.16 30.32 22.70 18.91 16.64
P & L Balance carried down 283.71 234.26 187.87 156.23 197.64 148.17
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 250.00 225.00 200.00 150.00 125.00 110.00
Dividend Per Share(Rs) 5.00 4.50 4.00 3.00 2.50 2.20
Earnings Per Share-Unit Curr 37.36 30.89 24.82 20.65 26.13 19.60
Book Value 37.98 34.16 30.32 22.70 18.91 16.64
Book Value(Adj)-Unit Curr 37.98 34.16 30.32 22.70 18.91 16.64

Shareholding Pattern

  • Promoter Group

    70.56%

  • Public Share Holding

    29.44%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,637,000 3.47 2,637,000 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50,995,982 67.09 50,995,982 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 53,632,982 70.56 53,632,982 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3,550 0.00 3,550 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,696,213 4.86 3,696,213 126
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 107,126 0.14 107,126 3
Mutual Funds / UTI 1,412,555 1.86 1,412,555 16
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 80,684 0.11 80,684 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,300,128 6.97 5,300,128 155
2] Non Institution
Bodies Corporate 688,997 0.91 683,997 362
Clearing Members 5 0.00 5 1
Directors of their Relatives 105,750 0.14 105,750 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,068,614 1.41 1,063,614 2,728
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 304,347 0.40 304,347 1,120
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,982,246 3.92 2,982,246 37
Individuals holding nominal share capital up to Rs. 1 lakh 9,005,536 11.85 8,299,391 88,218
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 10,624 0.01 10,624 5
Others 2,167,704 2.85 2,117,704 4
Sub Total 17,078,586 22.47 16,312,441 92,540
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 76,011,696 100.00 75,245,551 92,702

Company Background

Caplin Point Laboratories LtdPharmaceuticals - Indian - Formulations

  • Caplin Point Laboratories Ltd
  • BSE Code : 4464.0
  • ISIN : INE475E01026

  • Incorporation Year

    1990

  • Registered Office

    Ashvich Towers 3rd Floor
    No 3 Developed Plots Ind Estat, Chennai,
    Tamil Nadu-600096

  • Telephone

    91-44-24968000/71148000/28156653

  • FAX

    91-44-28154952

  • Chairman

    C C Paarthipan

  • Managing Director

    Sridhar Ganesan

  • Company Secretary

    Venkatram G

  • Auditor

    Brahmayya & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Integrated Registry Mgt Ser.Pv
    2nd Floor Kences Tow,
    1 Ramakrishna Street,Usman Road T.Nagar
    Mumbai - Chennai-600017

Caplin Point Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Caplin Point Lab 2,002.60 730.93 625.09 47.14 28.84
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92